MetaMol is an early stage biotech company with a focused mission to develop a highly specific diagnostic and therapeutic strategy to fight the spread of cancer.

Our strength lies in our research background. Over 6 years, our highly trained personnel under outstanding leadership, has studied an eminently promising drug target. We aim for excellence in creating novel ways to treat cancer.